<DOC>
	<DOCNO>NCT00505102</DOCNO>
	<brief_summary>The purpose study verify whether reduction cyclosporine dosage associate Everolimus administration may improve renal function compare patient maintain standard immunosuppressive therapy</brief_summary>
	<brief_title>Safe Renal Function In Long Term Heart Transplanted Patients</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>Heart Transplant patient 1 year followup Creatinine low 3.5 mg/dl GFR Higher 20 ml/min ( calculate CockcroftGault formula ) Cyclosporine maintenance immunosuppressive therapy Patient must able sign approve informed consent Prior History acute rejection within last 3 month Females childbearing age may include pregnancy exclude acceptable contraception measure use Patients recipient multiple organ transplant Prior current use sirolimus everolimus History acute rejection within last 6 month Coronary Artery Bypass Surgery cardiac surgery past 3 month Patient able attend followup evaluation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>Kidney Diseases</keyword>
	<keyword>Heart Transplantation</keyword>
	<keyword>Everolimus</keyword>
	<keyword>Cyclosporine Toxicity</keyword>
</DOC>